Table 5.
FRAP half time to recovery data
Control | GA | GA + GL | ||||
---|---|---|---|---|---|---|
Location | N | t½ | N | t½ | N | t½ |
All 3 zones | 57 | 2.21 ± 1.22 | 30 | 2.65 ± 1.30* | 30 | 2.56 ± 1.54† |
Peripapillary | 20 | 3.33 ± 1.01‡ | 10 | 3.65 ± 1.30^ | 10 | 4.19 ± 1.56^ |
0.75 mm | 20 | 1.52 ± 0.42 | 10 | 2.09 ± 0.62 | 10 | 1.51 ± 0.56 |
1.50 mm | 20 | 1.81 ± 1.01 | 10 | 2.52 ± 1.36 | 10 | 2.23 ± 0.82 |
difference from control: p = 0.001;
difference from control: p = 0.24;
GA= glyceraldehyde; GL= glaucoma induced via bead model;
difference of control peripapillary from other two control zones both p < 0.001;
difference from control of GA and GA+GL in peripapillary area, p = 0.20 and 0.049, respectively. N= samples per group, t½ in minutes; mean ± standard deviation.